PCCTC Leader Discusses Future of Liquid Biopsies in Prostate Cancer
November 22, 2016 | Press Releases
Dr. Howard I. Scher, PCCTC Scientific Oversight Committee Chair, speaks on predicting sensitivity to prostate cancer treatments.
Committed to world-class science!
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.